Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent
August 31, 2021 07:00 ET
|
MediPharm Labs Corp.
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter...
MediPharm Labs Australia Receives Government Grant to Assist with International Expansion
August 19, 2021 07:00 ET
|
MediPharm Labs Corp.
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s Manufacturing Modernisation program aimed at supporting manufacturers scaling their...
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
August 18, 2021 07:15 ET
|
MediPharm Labs Corp.
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits issued from Health Canada. Initial deliveries will be under the...
MediPharm Reports Second Quarter 2021 Results and Advances Pharmaceutical Strategy; Announces new Board Chair
August 16, 2021 07:15 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, Aug. 16, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results
August 10, 2021 07:00 ET
|
MediPharm Labs Corp.
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in research-driven...
MediPharm Labs Achieves Major Pharmaceutical Manufacturing Milestone: Receives Canadian GMP Pharmaceutical Drug Establishment Licence
July 14, 2021 07:00 ET
|
MediPharm Labs Corp.
Health Canada Drug Establishment Licence allows MediPharm Labs to conduct pharmaceutical manufacturing and sale of Active Pharmaceutical Ingredients and Pharmaceutical Drug ProductsMakes MediPharm...
MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
June 21, 2021 07:00 ET
|
MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders
June 10, 2021 07:01 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, June 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven...
MediPharm Labs Extends Strategic Partnership with ADREXpharma and continues to Build its Presence in Germany
June 08, 2021 07:01 ET
|
MediPharm Labs Corp.
MediPharm and ADREXpharma continue to lead the way addressing rising patient demand in the burgeoning German Medical Cannabis Market that saw sales increase 34% last year 128,000 active patients at...
REPEAT -- MediPharm Labs Launches High-CBD Wellness Oils in Quebec; Ships First Order of CBD 25 and CBD 50 Formulas Now Available for Retail Sale by SQDC
May 27, 2021 07:59 ET
|
MediPharm Labs Corp.
BARRIE, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven...